Ultragenyx Pharmaceutical(MX:RARE)
MX$256.000.00 (0.00%)
MX:RARE
Ultragenyx Pharmaceutical earnings date
MX$256.00
At close:0.00 (0.00%)
Ultragenyx Pharmaceutical (RARE) Q2 2025 Earnings Report
1 Followers
MX:RARE Q2 2025 EPS Results
- Actual EPS
- -MXN 21.75
- Consensus EPS
- -MXN 24.11
- Beat/Miss
- Beat by +MXN 2.36
- One Year Ago EPS
- -MXN 28.26
MX:RARE Q2 2025 Revenue Results
- Actual Revenue
- MXN 3.10B
- Expected Revenue
- MXN 3.01B
- Beat/Miss
- Beat by +MXN 83.32M
- YoY Revenue Growth
- +13.24%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 08/05/2025
- Time
- After Close
- Conference Call
- Tuesday, August 5, 2025
MX:RARE Upcoming Earnings
Ultragenyx Pharmaceutical's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q2 2025 Earnings Call Audio
MX:RARE Q2 2025 Earnings Call
0:00 / 0:00
Q2 2025 Earnings Slide Deck
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:RARE Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | 44.48- | -23.98 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | -20.45-21.56 | -33.65 | 35.91% (+12.08) | |
| Aug 04, 2026 | 2026 (Q2) | -23.09-16.73 | -21.75 | 23.08% (+5.02) | |
| May 05, 2026 | 2026 (Q1) | -27.66-34.20 | -29.19 | -17.20% (-5.02) | |
| Feb 12, 2026 | 2025 (Q4) | -20.32-23.98 | -25.84 | 7.19% (+1.86) | |
| Nov 04, 2025 | 2025 (Q3) | -22.94-33.65 | -26.03 | -29.29% (-7.62) | |
| Aug 05, 2025 | 2025 (Q2) | -24.11-21.75 | -28.26 | 23.03% (+6.51) | |
| May 06, 2025 | 2025 (Q1) | -29.71-29.19 | -37.74 | 22.66% (+8.55) | |
| Feb 13, 2025 | 2024 (Q4) | -24.31-25.84 | -28.26 | 8.55% (+2.42) | |
| Nov 05, 2024 | 2024 (Q3) | -27.59-26.03 | -41.45 | 37.22% (+15.43) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
